Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Ovarian Neoplasms

  Free Subscription


Articles published in Cancer Lett

Retrieve available abstracts of 28 articles:
HTML format
Text format



Single Articles


    October 2017
  1. PISTOLLATO F, Calderon Iglesias R, Ruiz R, Aparicio S, et al
    The use of natural compounds for the targeting and chemoprevention of ovarian cancer.
    Cancer Lett. 2017 Oct 7. pii: S0304-3835(17)30619.
    PubMed     Text format     Abstract available


  2. SHU T, Li Y, Wu X, Li B, et al
    Down-regulation of HECTD3 by HER2 inhibition makes serous ovarian cancer cells sensitive to platinum treatment.
    Cancer Lett. 2017 Oct 6. pii: S0304-3835(17)30609.
    PubMed     Text format     Abstract available


    September 2017
  3. LOUGHRAN EA, Phan RC, Leonard AK, Tarwater L, et al
    Multiparity Activates Interferon Pathways in Peritoneal Adipose Tissue and Decreases Susceptibility to Ovarian Cancer Metastasis in a Murine Allograft Model.
    Cancer Lett. 2017 Sep 27. pii: S0304-3835(17)30581.
    PubMed     Text format     Abstract available


    July 2017
  4. SAKAI K, Ukita M, Schmidt J, Wu L, et al
    Clonal composition of human ovarian cancer based on copy number analysis reveals a reciprocal relation with oncogenic mutation status.
    Cancer Lett. 2017 Jul 19. pii: S0304-3835(17)30439.
    PubMed     Text format     Abstract available


    May 2017
  5. LAKSHMINARASIMHAN R, Andreu-Vieyra C, Lawrenson K, Duymich CE, et al
    Down-regulation of ARID1A is sufficient to initiate neoplastic transformation along with epigenetic reprogramming in non-tumorigenic endometriotic cells.
    Cancer Lett. 2017 May 5. pii: S0304-3835(17)30312.
    PubMed     Text format     Abstract available


    April 2017
  6. SOKOLENKO AP, Savonevich EL, Ivantsov AO, Raskin GA, et al
    Rapid selection of BRCA1-proficient tumor cells during neoadjuvant therapy for ovarian cancer in BRCA1 mutation carriers.
    Cancer Lett. 2017 Apr 1. pii: S0304-3835(17)30218.
    PubMed     Text format     Abstract available


    February 2017
  7. HU Y, Li D, Wu A, Qiu X, et al
    TWEAK-stimulated macrophages inhibit metastasis of epithelial ovarian cancer via exosomal shuttling of microRNA.
    Cancer Lett. 2017 Feb 16. pii: S0304-3835(17)30109.
    PubMed     Text format     Abstract available


    January 2017
  8. DEAN M, Davis DA, Burdette JE
    Activin A Stimulates Migration of the Fallopian Tube Epithelium, an Origin of High-Grade Serous Ovarian Cancer, through Non-Canonical Signaling.
    Cancer Lett. 2017 Jan 20. pii: S0304-3835(17)30034.
    PubMed     Text format     Abstract available


    December 2016
  9. LUO T, Sun J, Zhu S, He J, et al
    Ultrasound-mediated destruction of oxygen and paclitaxel loaded dual-targeting microbubbles for intraperitoneal treatment of ovarian cancer xenografts.
    Cancer Lett. 2016 Dec 30. pii: S0304-3835(16)30802.
    PubMed     Text format     Abstract available


  10. TODESCHINI P, Salviato E, Paracchini L, Ferracin M, et al
    Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: a validation across two independent cohorts.
    Cancer Lett. 2016 Dec 22. pii: S0304-3835(16)30780.
    PubMed     Text format     Abstract available


  11. AUER K, Bachmayr-Heyda A, Aust S, Grunt TW, et al
    Comparative transcriptome analysis links distinct peritoneal tumor spread types, miliary and non-miliary, with putative origin, tubes and ovaries, in high grade serous ovarian cancer.
    Cancer Lett. 2016 Dec 7. pii: S0304-3835(16)30739.
    PubMed     Text format     Abstract available


    November 2016
  12. JEONG JY, Kang HY, Kim TH, Kim GI, et al
    MicroRNA-136 inhibits cancer stem cell activity and enhances the anti-tumor effect of paclitaxel against chemoresistant ovarian cancer cells by targeting Notch3.
    Cancer Lett. 2016 Nov 22. pii: S0304-3835(16)30705.
    PubMed     Text format     Abstract available


    September 2016
  13. YOU J, Liu J, Bao Y, Wang L, et al
    SEI1 induces genomic instability by inhibiting DNA damage response in ovarian cancer.
    Cancer Lett. 2016 Sep 30. pii: S0304-3835(16)30574.
    PubMed     Text format     Abstract available


  14. LI Q, Zhang C, Chen R, Xiong H, et al
    Disrupting MALAT1/miR-200c sponge decreases invasion and migration in endometrioid endometrial carcinoma.
    Cancer Lett. 2016 Sep 28. pii: S0304-3835(16)30561.
    PubMed     Text format     Abstract available


    April 2016
  15. LUO Z, Wang Q, Lau WB, Lau B, et al
    Tumor microenvironment: The culprit for ovarian cancer metastasis?
    Cancer Lett. 2016 Apr 27. pii: S0304-3835(16)30274.
    PubMed     Text format     Abstract available


  16. MALEVA KOSTOVSKA I, Wang J, Bogdanova N, Schurmann P, et al
    Rare ATAD5 missense variants in breast and ovarian cancer patients.
    Cancer Lett. 2016 Apr 1. pii: S0304-3835(16)30209.
    PubMed     Text format     Abstract available


    March 2016
  17. TONG H, Ke JQ, Jiang FZ, Wang XJ, et al
    Tumor-associated macrophage-derived CXCL8 could induce ERalpha suppression via HOXB13 in endometrial cancer.
    Cancer Lett. 2016 Mar 24. pii: S0304-3835(16)30196.
    PubMed     Text format     Abstract available


  18. TANG S, Xiang T, Huang S, Zhou J, et al
    Ovarian cancer stem-like cells differentiate into endothelial cells and participate in tumor angiogenesis through autocrine CCL5 signaling.
    Cancer Lett. 2016 Mar 23. pii: S0304-3835(16)30194.
    PubMed     Text format     Abstract available


    January 2016
  19. AI Z, Lu Y, Qiu S, Fan Z, et al
    Overcoming cisplatin resistance of ovarian cancer cells by targeting HIF-1-regulated cancer metabolism.
    Cancer Lett. 2016 Jan 19. pii: S0304-3835(16)00021.
    PubMed     Text format     Abstract available


    December 2015
  20. GWAK H, Kim S, Dhanasekaran DN, Song YS, et al
    Resveratrol triggers ER stress-mediated apoptosis by disrupting N-linked glycosylation of proteins in ovarian cancer cells.
    Cancer Lett. 2015 Dec 15. pii: S0304-3835(15)00722.
    PubMed     Text format     Abstract available


    November 2015
  21. SEO JA, Kim B, Dhanasekaran DN, Tsang BK, et al
    Curcumin induces apoptosis by inhibiting sarco/endoplasmic reticulum ca ATPase activity in ovarian cancer cells.
    Cancer Lett. 2015 Nov 19. pii: S0304-3835(15)00697.
    PubMed     Text format     Abstract available


    September 2015
  22. THIBAULT B, Clement E, Zorza G, Meignan S, et al
    F14512, a polyamine-vectorized inhibitor of topoisomerase II, exhibits a marked anti-tumor activity in ovarian cancer.
    Cancer Lett. 2015 Sep 23. pii: S0304-3835(15)00586.
    PubMed     Text format     Abstract available


  23. GORODNOVA TV, Sokolenko AP, Ivantsov AO, Iyevleva AG, et al
    High response rates to neoadjuvant platinum-based therapy in ovarian cancer patients carrying germ-line BRCA mutation.
    Cancer Lett. 2015 Sep 2. pii: S0304-3835(15)00569.
    PubMed     Text format     Abstract available


    August 2015
  24. ALTMAN MK, Alshamrani AA, Jia W, Nguyen H, et al
    Suppression of the GTPase-activating protein RGS10 increases Rheb-GTP and mTOR signaling in ovarian cancer cells.
    Cancer Lett. 2015 Aug 28. pii: S0304-3835(15)00541.
    PubMed     Text format     Abstract available


    July 2015
  25. HOVER LD, Young CD, Bhola NE, Wilson AJ, et al
    Small molecule inhibitor of the bone morphogenetic protein pathway DMH1 reduces ovarian cancer cell growth.
    Cancer Lett. 2015 Jul 30. pii: S0304-3835(15)00487.
    PubMed     Text format     Abstract available


  26. TANG MK, Wong AS
    Exosomes: Emerging biomarkers and targets for ovarian cancer.
    Cancer Lett. 2015 Jul 17. pii: S0304-3835(15)00456.
    PubMed     Text format     Abstract available


    March 2015
  27. CHEN S, Chen X, Xiu YL, Sun KX, et al
    MicroRNA-490-3P targets CDK1 and inhibits ovarian epithelial carcinoma tumorigenesis and progression.
    Cancer Lett. 2015 Mar 25. pii: S0304-3835(15)00221.
    PubMed     Text format     Abstract available


    February 2015
  28. WANG H, Bao W, Jiang F, Che Q, et al
    Mutant p53 (p53-R248Q) functions as an oncogene in promoting endometrial cancer by up-regulating REGgamma
    Cancer Lett. 2015 Feb 16. pii: S0304-3835(15)00132.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: